BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 16638699)

  • 1. Obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease: a cross-sectional case-control study.
    Lee S; Jin Kim Y; Yong Jeon T; Hoi Kim H; Woo Oh S; Park Y; Soo Kim S
    Scand J Gastroenterol; 2006 May; 41(5):566-72. PubMed ID: 16638699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of non-alcoholic fatty liver disease in obese children.
    Sartorio A; Del Col A; Agosti F; Mazzilli G; Bellentani S; Tiribelli C; Bedogni G
    Eur J Clin Nutr; 2007 Jul; 61(7):877-83. PubMed ID: 17151586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis].
    Choi SY; Kim D; Kang JH; Park MJ; Kim YS; Lim SH; Kim CH; Lee HS
    Korean J Hepatol; 2008 Mar; 14(1):77-88. PubMed ID: 18367860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A vegetarian diet does not protect against nonalcoholic fatty liver disease (NAFLD): A cross-sectional study between Buddhist priests and the general population.
    Choi SH; Oh DJ; Kwon KH; Lee JK; Koh MS; Lee JH; Kang HW
    Turk J Gastroenterol; 2015 Jul; 26(4):336-43. PubMed ID: 26039004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.
    Koller T; Kollerova J; Hlavaty T; Huorka M; Payer J
    Scand J Gastroenterol; 2012 Feb; 47(2):197-203. PubMed ID: 22182015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and associated metabolic factors of fatty liver disease in the elderly.
    Wang Z; Xu M; Peng J; Jiang L; Hu Z; Wang H; Zhou S; Zhou R; Hultström M; Lai EY
    Exp Gerontol; 2013 Aug; 48(8):705-9. PubMed ID: 23721951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic fatty liver disease is closely associated with sub-clinical inflammation: a case-control study on Asian Indians in North India.
    Nigam P; Bhatt SP; Misra A; Vaidya M; Dasgupta J; Chadha DS
    PLoS One; 2013; 8(1):e49286. PubMed ID: 23326306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures.
    Alavian SM; Mohammad-Alizadeh AH; Esna-Ashari F; Ardalan G; Hajarizadeh B
    Liver Int; 2009 Feb; 29(2):159-63. PubMed ID: 18492015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance and metabolic syndrome in patients with NAFLD but without diabetes: effect of a 6 month regime intervention.
    Cankurtaran M; Tayfur O; Yavuz BB; Geyik S; Akhan O; Arslan S
    Acta Gastroenterol Belg; 2007; 70(3):253-9. PubMed ID: 18074733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography.
    Açikel M; Sunay S; Koplay M; Gündoğdu F; Karakelleoğlu S
    Anadolu Kardiyol Derg; 2009 Aug; 9(4):273-9. PubMed ID: 19666428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasonographic and biochemical evaluation of visceral obesity in obese women with non-alcoholic fatty liver disease.
    Fenkci S; Rota S; Sabir N; Akdag B
    Eur J Med Res; 2007 Feb; 12(2):68-73. PubMed ID: 17369120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between non-alcoholic fatty liver disease and insulin resistance in 20 obese children and adolescents.
    Ciba I; Widhalm K
    Acta Paediatr; 2007 Jan; 96(1):109-12. PubMed ID: 17187615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.
    Li XD; Qiu BH; Su FC; Sun SX
    Clin Exp Hypertens; 2016; 38(7):639-643. PubMed ID: 27680771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents.
    Nadeau KJ; Ehlers LB; Zeitler PS; Love-Osborne K
    Pediatr Diabetes; 2009 Feb; 10(1):5-13. PubMed ID: 18721166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk factors for ultrasound-diagnosed non-alcoholic fatty liver disease among adolescents.
    Fu CC; Chen MC; Li YM; Liu TT; Wang LY
    Ann Acad Med Singap; 2009 Jan; 38(1):15-7. PubMed ID: 19221666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease.
    Pacifico L; Anania C; Martino F; Cantisani V; Pascone R; Marcantonio A; Chiesa C
    Hepatology; 2010 Nov; 52(5):1643-51. PubMed ID: 20890890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease.
    Lebensztejn DM; Wojtkowska M; Skiba E; Werpachowska I; Tobolczyk J; Kaczmarski M
    Adv Med Sci; 2009; 54(2):177-82. PubMed ID: 20022856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not.
    Younossi ZM; Otgonsuren M; Venkatesan C; Mishra A
    Metabolism; 2013 Mar; 62(3):352-60. PubMed ID: 22999011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.